3 Mid-Cap Biotechs Analysts Think Can Double Posted byMarketBeat Staff January 21, 2022 Leave a comment on 3 Mid-Cap Biotechs Analysts Think Can Double Biotech stocks are notoriously among the most volatile on the exchange which can be both a blessing and a curse. Hardest hit during market downturns, they can be the fastest…